ClinicalTrials.gg
Not yet recruitingNCT07079306Updated Oct 14, 2026

ChatGPT-Supported Text Messaging Program for Smoking Cessation

An interventional study of BeFree+Bot and BeFree in Smoking Cessation, sponsored by George Washington University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by George Washington University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 7, 2026Primary completion movedStudy completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 921 studies in Smoking Cessation with a site in United States — 98 open to participants now, 127 under way, 7 of them phase 3. Smoking Cessation · United States.

Planned enrollment
388th of 873
180 · median 148
Started
2026
with 36 others
No phase
513 of 921
69 open now
Primary completion
2027-03
later than 46 of 126 live
Registered
881st of 921
by date

Among the 921 studies in Smoking Cessation with a site in United States, this one is the 388th largest by planned enrollment of the 873 interventional ones that give a count, is one of 37 that started in 2026, is one of 513 with no phase, reaches primary completion later than 46 of the 126 other live ones, and was the 881st registered.

Smoking Cessation

1,583 studies on the registry are indexed under Smoking Cessation; 196 are open to participants now.

Browse Smoking Cessation studies →

Open to participants now

98 of the 921 studies in Smoking Cessation with a site in United States are open now. Recruiting first, the newest first:

93 more — sign in →

All 98 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 134 Smoking Cessation studies recruiting now, 92 (69%) set no upper age limit and 35 (26%) stop at 75 or younger; 6 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 921 studies in Smoking Cessation with a site in United States, or all of them as a file.
02

Study summary

The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.

03

Conditions studied

  • Smoking Cessation

Browse trials for

Keywords

  • smoking cessation
  • ai
  • text messaging
04

Who can participate

The criteria were revised on the registry on Oct 7, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • lives in the US
  • smoked a cigarette within the last 7 days
  • has a mobile phone
  • willing to receive text messages about the health effects of smoking on their mobile phone for 30 days
  • willing to set a quit date in the next 7 days
  • not pregnant

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Intervention

    Text messages about quitting smoking and access to specialized ChatGPT chatbot

    Behavioral: BeFree+Bot

  • Active comparator
    Control

    Text messages about quitting smoking

    Behavioral: BeFree

Interventions

  • BehavioralBeFree+Bot

    Text messaging program called BeFree and access to BBot, ChatGPT chatbot

  • BehavioralBeFree

    Text messaging program called BeFree

06

What researchers measure

Primary outcomes

  1. Continuous abstinence

    the longest continuous period (in days) that you did not smoke a cigarette

    Time frame: at 1 month follow-up

07

Study locations

1 site
  • Prolific
    Washington D.C., District of Columbia 20052, United States
08

References and documents

Individual participant data

Plan to share: No — It is a small pilot study

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Mar 2027, 5 months later.

Of 547 non-industry interventional studies with no phase under Smoking Cessation, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 5 months is below that.

Counting every sponsor, half of 564 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Dec 2026 → Mar 2027 and completion Jan 2027 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2025
First posted
Jul 23, 2025
StartEst.
Oct 2026
Primary completionEst.
Mar 30, 2027was Dec 2026
CompletionEst.
Oct 30, 2027was Jan 2027
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 30, 2026→Mar 30, 2027
Oct 7, 2026
Study completion
Jan 30, 2027→Oct 30, 2027
Oct 7, 2026
Enrollment
150→180
Oct 7, 2026
Eligibility
2 inclusion criteria added
What changed in the criteria
Inclusion criteria
  • Addedwilling to set a quit date in the next 7 days
  • Addednot pregnant
Oct 7, 2026
Show all 2 updates
  1. Oct 14, 2026
    Minor edits only
    + 1 other change: responsible party
  2. Oct 7, 2026
    Primary completion Dec 30, 2026→Mar 30, 2027
    Study completion Jan 30, 2027→Oct 30, 2027
    Enrollment 150→180
    Eligibility 2 inclusion criteria added
    What changed in the criteria
    Inclusion criteria
    • Addedwilling to set a quit date in the next 7 days
    • Addednot pregnant
    + 2 other changes: verification date and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07079306
Responsible party
Lorien Abroms (Principal Investigator, George Washington University) — Principal investigator
First posted
Jul 23, 2025
Start date
Oct 2026 (estimated)
Primary completion
Mar 30, 2027 (estimated)
Completion
Oct 30, 2027 (estimated)
Last update
Oct 14, 2026

Study contacts

Lorien Abroms, ScD
Contact
lorien@gwu.edu
202-994-3518

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion